Blog

BC Pharmacare to cover SGLT-2 inhibitors and to delist the Lantus brand of insulin glargine U100

Announcements, Living With Diabetes

Yesterday BC Minister of Health Adrian Dix announced Pharmacare coverage of the SGLT-2 inhibitor class represented by empagliflozin (Jardiance). Although BCDiabetes would have preferred that all three SGLT2 inhibitors on the Canadian market be covered, the long overdue announcement was most welcome news. Our readers will be aware of the long-running BCDiabetes advocacy campaign for […]

READ MORE

See Dr. Elliott interpret reports from Freestyle Libre – Facebook livestream from April 30, 2019

Living With Diabetes

On April 30, Medical Director Dr. Tom Elliott spoke with patients at the BC Diabetes Freestyle Libre Interpretation Class, and livestreamed it on Facebook to share with patients who could not attend. In this video, he explains the basics of blood sugar control, including the effects of diet, exercise, stress, basal and rapid insulin, and […]

READ MORE

2019 BC Diabetes Fundraiser Photos

Events, Uncategorized

Highlights from our first fundraiser event, “Changing Lives Through Discovery and Research,” on April 4, 2019 at Science World in Vancouver.

READ MORE

CREDENCE – more evidence of benefits with SGLT2 inhibitors – write to your MLA

Research

Today (2019-Apr-15) the results of the much anticipated CREDENCE study which examined the benefits of canagliflozin (a member of the SGLT2 inhibitor class) were presented in Melbourne, Australia. Striking benefits were shown for individuals with Type 2 diabetes-related kidney disease including a 30% reduction in progression of kidney disease, 20% reduction in cardiovascular death/heart attack/stroke […]

READ MORE

Why you should write your politician about life-saving diabetes treatments

Living With Diabetes

BCDiabetes is actively lobbying with Pharmacare to cover a number of life-saving therapies and devices. At the top of our list is the SGLT2 inhibitor class of medication: see this video made with Diabetes Canada & previous blogs here, here and here. SGLT2 inhibitors are covered in every Canadian province except BC. In the 2019-Feb […]

READ MORE

Statins for all?

Living With Diabetes, News & Media, Research

On February 1, 2019, the prestigious medical journal the Lancet published a meta-analysis examining potential benefits the statin and class of medication. The article confirmed and extended the powerful evidence for benefit for the use of statins in people with a previous history of heart disease, stroke and for those with diabetes.  It showed that […]

READ MORE

HCTZ and Risk of Skin Cancer

News & Media

Yesterday Health Canada issued a warning around HCTZ (hydrochlorothiazide), a commonly used diuretic blood pressure lowering medication: The warning was issued because of new evidence suggesting a 4-fold increased risk of non-melanoma skin cancer in individuals who have taken HCTZ for 3+ years. Non-melanoma skin cancer is made up of  basal-cell skin cancer (BCC) & […]

READ MORE

BC Diabetes Fundraising Event

Announcements, Events, News & Media

I began specialist diabetes practice in 1992 – with it began my lifetime mission to optimize care and improve outcomes for every British Columbian living with diabetes.  As my staff grew I realized that everything depended on teamwork – thus in 2005 was born BCDiabetes.   BCDiabetes, with its dedicated staff of 14, is now […]

READ MORE

John Daly from CKNW and Dr. Tom Elliott discuss recent advances in diabetes care

Announcements

BCDiabetes Medical Director, Dr. Tom Elliott, will be on CKNW radio! Dr. Tom Elliott will speak on John Daly’s radio show Back on the Beat this Saturday, 11:00 am about the benefits of CGM/Sensors, insulin pumps, and GLP-1 agonists. Dr. Tom Elliott will also speak about the new “Trial to Assess Chelation Therapy”. BCDiabetes is […]

READ MORE

Health Canada approves insulin pump with partial artificial pancreas capability

Announcements, Living With Diabetes, News & Media

2018-Oct-10 saw Health Canada approve the Medtronic 670G insulin pump, the first of its kind in Canada to support closed-loop functionality for basal insulin.  This innovation, the first step towards an artificial pancreas, is welcome news for every individual with diabetes who is an intensive insulin user (either a pumper or taking multiple daily shots). […]

READ MORE
Translate »